Edwards Lifesciences director buys 3,000 shares
Kieran Gallahue, a member of the board of directors at Edwards Lifesciences (EW), bought 3,000 shares of the company’s common stock on Feb. 3. At $99.10 per share, Gallahue paid a total of $270,300 for the new shares.
Already a member?
Login to see your Insider Activity Trade Idea.
Not yet a member?
You can receive four timely bull-put credit spreads each market day by joining our InvestorsKeyhole Daily Trade Alerts Service. Our analysts scour the news looking for unusual options activity, how insiders are trading, and breaking news, and publish trades accordingly.
Become A Member
About Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters and retractors, and monitoring systems used to measure a patient's heart function during surgery.